10/31
09:52 am
etnb
89BIO (NASDAQ:ETNB) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Neutral
Report
89BIO (NASDAQ:ETNB) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
10/22
06:57 am
etnb
89BIO (NASDAQ:ETNB) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Neutral
Report
89BIO (NASDAQ:ETNB) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
10/16
04:58 pm
etnb
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 89bio, Inc. (Nasdaq - ETNB), Barinthus Biotherapeutics plc (Nasdaq - BRNS), Verint Systems Inc. (Nasdaq - VRNT), Dayforce, Inc. (NYSE- DAY)
Low
Report
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 89bio, Inc. (Nasdaq - ETNB), Barinthus Biotherapeutics plc (Nasdaq - BRNS), Verint Systems Inc. (Nasdaq - VRNT), Dayforce, Inc. (NYSE- DAY)
10/8
11:22 am
etnb
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 89bio, Inc. (Nasdaq - ETNB), Barinthus Biotherapeutics plc (Nasdaq - BRNS), Verint Systems Inc. (Nasdaq - VRNT), Dayforce, Inc. (NYSE- DAY)
Low
Report
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 89bio, Inc. (Nasdaq - ETNB), Barinthus Biotherapeutics plc (Nasdaq - BRNS), Verint Systems Inc. (Nasdaq - VRNT), Dayforce, Inc. (NYSE- DAY)
10/6
05:10 pm
etnb
89bio Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 89bio, Inc. - ETNB
Low
Report
89bio Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 89bio, Inc. - ETNB
10/2
02:05 am
etnb
89BIO (NASDAQ:ETNB) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
89BIO (NASDAQ:ETNB) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
10/1
04:51 pm
etnb
Roche commences tender offer for all shares of 89bio, Inc. for $14.50 per share in cash, plus a non-tradeable contingent value right for up to $6.00 per share in cash [Yahoo! Finance]
Low
Report
Roche commences tender offer for all shares of 89bio, Inc. for $14.50 per share in cash, plus a non-tradeable contingent value right for up to $6.00 per share in cash [Yahoo! Finance]
9/30
12:44 pm
etnb
89bio, Inc. (ETNB) Shareholders to Receive Up to $3.5B Total in Roche Buyout Deal [Yahoo! Finance]
Low
Report
89bio, Inc. (ETNB) Shareholders to Receive Up to $3.5B Total in Roche Buyout Deal [Yahoo! Finance]
9/29
02:38 pm
etnb
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PINC, MTSR, ETNB on Behalf of Shareholders
Low
Report
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PINC, MTSR, ETNB on Behalf of Shareholders